These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10969615)

  • 1. [Chronochemotherapy].
    Dogliotti L; Garufi C; Iacobelli S
    Tumori; 2000; 86(3 Suppl):S32-6. PubMed ID: 10969615
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronotherapy with 5-fluorouracil, oxaliplatin, and folinic acid in colorectal cancer.
    Sandor V
    Lancet; 1997 Nov; 350(9087):1325-6. PubMed ID: 9357429
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chronotherapy].
    Garufi C; Aschelter AM; Zappalà AR; Vanni B; Terzoli E
    Tumori; 2001; 87(6):A26-7. PubMed ID: 11995702
    [No Abstract]   [Full Text] [Related]  

  • 4. [Oxaliplatin and fluorouracil: bolus coadministration regimens].
    Zaniboni A; Meriggi F
    Tumori; 2001; 87(6):A24-5. PubMed ID: 11995700
    [No Abstract]   [Full Text] [Related]  

  • 5. [Future therapeutic prospectives for the treatment of advanced cancer of the colorectum: our experience with oxaliplatin combined with fluorofolates in chronoinfusions].
    Bumma C; Montrucchio G; Manzin E; Oletti MV
    Tumori; 2000; 86(3 Suppl):S26-8. PubMed ID: 10969613
    [No Abstract]   [Full Text] [Related]  

  • 6. Capecitabine plus oxaliplatin vs infusional 5-fluorouracil plus oxaliplatin in the treatment of colorectal cancer. Pro: The CapeOx regimen is preferred over FOLFOX.
    Chang DZ; Abbruzzese JL
    Clin Adv Hematol Oncol; 2005 May; 3(5):400-4. PubMed ID: 16167013
    [No Abstract]   [Full Text] [Related]  

  • 7. [Standard chemotherapy for colonic neoplasms].
    Hyodo I
    Nihon Naika Gakkai Zasshi; 2007 Feb; 96(2):283-8. PubMed ID: 17370594
    [No Abstract]   [Full Text] [Related]  

  • 8. Is oxaliplatin combined with weekly bolus 5-fluorouracil and leucovorin an option for stage II and III colon cancer?
    Twelves C
    Nat Clin Pract Oncol; 2008 Feb; 5(2):72-3. PubMed ID: 18030299
    [No Abstract]   [Full Text] [Related]  

  • 9. A meta-analysis of chemotherapy regimen fluorouracil/leucovorin/oxaliplatin compared with fluorouracil/leucovorin in treating advanced colorectal cancer.
    Chen ML; Fang CH; Liang LS; Dai LH; Wang XK
    Surg Oncol; 2010 Mar; 19(1):38-45. PubMed ID: 19345093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chronotherapy with 5-fluorouracil folinic acid and oxaliplatin delivered over 48 hours every second week in colorectal cancer. The CHC-Liège experience (Belgium)].
    Focan C; Demolin G; Kreutz F; Graas MP; Longrée L; Matus G; Moeneclaey N; Focan-Henrard D
    Pathol Biol (Paris); 2013 Oct; 61(5):e71-4. PubMed ID: 23089329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scheduling of fluorouracil: a forget-me-not in the jungle of doublets.
    Sobrero AF
    J Clin Oncol; 2004 Jan; 22(1):4-6. PubMed ID: 14665617
    [No Abstract]   [Full Text] [Related]  

  • 12. [Oxaliplatin in combination with 5-fluoro-uracil and folinic acid as treatment of metastatic colorectal cancer].
    André T; Louvet C; Maindrault-Goebel F; Gramont AD
    Bull Cancer; 2001 Aug; 88 Spec No():S20-5. PubMed ID: 11567910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capecitabine plus oxaliplatin vs infusional 5-fluorouracil plus oxaliplatin in the treatment of colorectal cancer. Con: Pumpin' FU (or, avoiding that oral fixation).
    Hochster HS
    Clin Adv Hematol Oncol; 2005 May; 3(5):405-6. PubMed ID: 16167014
    [No Abstract]   [Full Text] [Related]  

  • 14. [The major response of metastatic kidney cancer to the combination of oxaliplatin, 5-fluorouracil and folinic acid (FOX-FOL)].
    Chauffert B; Bonnotte B; Chvetzoff G; Flesch M
    Presse Med; 1998 May; 27(18):859. PubMed ID: 9767871
    [No Abstract]   [Full Text] [Related]  

  • 15. Mediastinal extravasation of oxaliplatin.
    Pijaume CP; Saigí E
    Clin Adv Hematol Oncol; 2012 Aug; 10(8):548-9. PubMed ID: 23073057
    [No Abstract]   [Full Text] [Related]  

  • 16. [FOLFOX].
    Mishima H; Ikenaga M; Tsujinaka T; Yasui M; Kashiwazaki M; Miyazaki M; Hirao M; Fujitani K; Nakamori S
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):911-4. PubMed ID: 16835479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaphylactic reaction to oxaliplatin: a case report.
    Larzillière I; Brandissou S; Breton P; Lingoungou A; Gargot D; Ramain JP; Harnois C
    Am J Gastroenterol; 1999 Nov; 94(11):3387-8. PubMed ID: 10566767
    [No Abstract]   [Full Text] [Related]  

  • 18. Bevacizumab plus FOLFIRI or FOLFOX as third-line or later treatment in patients with metastatic colorectal cancer after failure of 5-fluorouracil, irinotecan, and oxaliplatin: a retrospective analysis.
    Kang BW; Kim TW; Lee JL; Ryu MH; Chang HM; Yu CS; Kim JC; Kim JH; Kang YK; Lee JS
    Med Oncol; 2009; 26(1):32-7. PubMed ID: 18498064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interstitial lung disease caused by oxaliplatin. An uncommon but not unknown complication.
    Sánchez Cendra C; Juez Martel I; Gutierrez Abad D
    Arch Bronconeumol; 2017 Apr; 53(4):213-215. PubMed ID: 27756654
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer.
    Giacchetti S; Perpoint B; Zidani R; Le Bail N; Faggiuolo R; Focan C; Chollet P; Llory JF; Letourneau Y; Coudert B; Bertheaut-Cvitkovic F; Larregain-Fournier D; Le Rol A; Walter S; Adam R; Misset JL; Lévi F
    J Clin Oncol; 2000 Jan; 18(1):136-47. PubMed ID: 10623704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.